PRAME Is a Golgi-Targeted Protein That Associates with the Elongin BC Complex and Is Upregulated by Interferon-Gamma and Bacterial Pamps

Total Page:16

File Type:pdf, Size:1020Kb

PRAME Is a Golgi-Targeted Protein That Associates with the Elongin BC Complex and Is Upregulated by Interferon-Gamma and Bacterial Pamps PRAME Is a Golgi-Targeted Protein That Associates with the Elongin BC Complex and Is Upregulated by Interferon-Gamma and Bacterial PAMPs Frances R. Wadelin, Joel Fulton, Hilary M. Collins, Nikolaos Tertipis, Andrew Bottley, Keith A. Spriggs, Franco H. Falcone, David M. Heery* School of Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, University Park, Nottingham, United Kingdom Abstract Preferentially expressed antigen in melanoma (PRAME) has been described as a cancer-testis antigen and is associated with leukaemias and solid tumours. Here we show that PRAME gene transcription in leukaemic cell lines is rapidly induced by exposure of cells to bacterial PAMPs (pathogen associated molecular patterns) in combination with type 2 interferon (IFNc). Treatment of HL60 cells with lipopolysaccharide or peptidoglycan in combination with IFNc resulted in a rapid and transient induction of PRAME transcription, and increased association of PRAME transcripts with polysomes. Moreover, treatment with PAMPs/IFNc also modulated the subcellular localisation of PRAME proteins in HL60 and U937 cells, resulting in targeting of cytoplasmic PRAME to the Golgi. Affinity purification studies revealed that PRAME associates with Elongin B and Elongin C, components of Cullin E3 ubiquitin ligase complexes. This occurs via direct interaction of PRAME with Elongin C, and PRAME colocalises with Elongins in the Golgi after PAMP/IFNc treatment. PRAME was also found to co-immunoprecipitate core histones, consistent with its partial localisation to the nucleus, and was found to bind directly to histone H3 in vitro. Thus, PRAME is upregulated by signalling pathways that are activated in response to infection/inflammation, and its product may have dual functions as a histone-binding protein, and in directing ubiquitylation of target proteins for processing in the Golgi. Citation: Wadelin FR, Fulton J, Collins HM, Tertipis N, Bottley A, et al. (2013) PRAME Is a Golgi-Targeted Protein That Associates with the Elongin BC Complex and Is Upregulated by Interferon-Gamma and Bacterial PAMPs. PLoS ONE 8(2): e58052. doi:10.1371/journal.pone.0058052 Editor: William R. Abrams, New York University, United States of America Received January 5, 2012; Accepted January 30, 2013; Published February 27, 2013 Copyright: ß 2013 Wadelin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: This work was funded by Leukaemia Lymphoma Research via a clinical training fellowship to FRW (07064). JF was funded by the Royal Pharmaceutical Society of Great Britain via an Academic Excellence Award to DMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. * E-mail: [email protected] Introduction pathogenic bacteria [16], although until recently there has been little insight into its functions in mammalian cells. Nuclear PRAME/MAPE/OIP4 is an atypical cancer-testis antigen localised PRAME has been implicated in transcriptional repres- whose expression is associated with leukaemias and a large sion via association with retinoic acid receptor complexes [17]. proportion of solid tumours (reviewed in [1]). Unlike other More recently, while this study was in progress, PRAME was cancer-testis antigens whose expression is restricted to testis, the shown to be a chromatin-associated protein enriched at nuclear PRAME gene shows low level expression in other normal tissues factor Y (NFY) target genes, in association with Elongin and including endometrium, ovary and placenta [2]. The restricted Cullin-2 proteins [18]. However, a large proportion of endog- expression pattern of PRAME in normal tissues and its enous PRAME protein is observed in the cytoplasmic compart- overexpression in tumours renders it a useful marker of minimal ment in different cell lines [1,19]. Given its reported interaction residual disease after chemotherapy, and an attractive target for with bacterial outer membrane proteins [16] and the rapid immunotherapy, particularly in acute myeloid leukaemia (AML) evolution of the PRAME multigene family in humans [15], and chronic myeloid leukaemia (CML) [2,3,4,5,6,7,8,9,10,11,12]. similar to the Nacht, LRR, PYD domain (NALP) gene family In PRAME-negative leukaemias the gene can be induced by [20], we hypothesised that PRAME might be regulated by demethylating agents [2,13,14], but little else is known regarding signalling pathways activated in proinflammatory responses. We pathways that regulate PRAME expression. therefore set out to investigate whether PRAME expression is PRAME is a member of a rapidly evolving multigene family, modulated by signalling molecules such as IFNc or microbial and encodes a leucine-rich repeat (LRR) protein sharing PAMPs. We also endeavoured to isolate PRAME-interacting structural similarity with Toll-like receptors [1,15]. The extensive proteins, to provide further insight into its cellular functions. duplication rate of PRAME and other cancer testis antigen genes is suggestive of roles in chemosensing, reproduction or immunity [15]. PRAME was originally identified in a yeast two-hybrid screen for proteins that bind outer membrane proteins of PLOS ONE | www.plosone.org 1 February 2013 | Volume 8 | Issue 2 | e58052 Function and Regulation of PRAME Results the cytoplasm of these cells within 24 hrs of transfection (Fig. 2A). Staining with a specific antibody recognising PRAME confirmed Upregulation of PRAME expression by IFNc and bacterial the identity of the recombinant PRAME-EGFP and PRAME- PAMPs FLAG constructs, in contrast to neighbouring non-transfected cells PRAME protein contains a series of leucine-rich repeats similar which showed negligible endogenous levels of PRAME (Fig. 2A). to those found in the LRR protein family and is predicted to be In contrast to PRAME-EGFP, EGFP alone showed approximately structurally similar to human Toll-like receptors (TLRs) [1,15]. equal distribution in the nucleus and cytoplasm whereas co- Unlike the membrane-associated TLRs, PRAME is an intracel- transfected PRAME-FLAG was predominantly cytoplasmic lular protein found in both the nuclear and cytoplasmic (Fig. 2A, lower panels). These observations are consistent with compartments [1]. TLRs function in innate immunity as sensors suggestions that PRAME is likely to have both nuclear and of microbial PAMPs or other ligands, and their expression is cytoplasmic functions, although the distribution between these regulated by these molecules and also by IFNc, a proinflammatory compartments may vary in different cell types and conditions. cytokine produced in response to infection. We therefore assessed To determine whether exposure to bacterial PAMPs/IFNc had whether PRAME expression in leukaemic cells such as HL60 might any effect on the subcellular localisation of PRAME, we be modulated by exposure to lipopolysaccharide (LPS) and IFNc, performed immunofluorescence staining of cells exposed to these either as single inducing agents or in combination. HL60 agents, or controls. A longer treatment time (4 hours) was used to leukaemic cells have low levels of PRAME transcripts [1], and allow for expression of PRAME proteins in the cells. As shown in are known to express TLR2 and TLR4 [21]. Treatment of HL60 Fig. 2B, treatment of HL60 cells with LPS/IFNc (middle panels) cells with IFNc or LPS alone did not significantly alter the or PGN/IFNc (lower panels) for 4 hours resulted in localisation of expression of PRAME (as determined by RT-qPCR – data not PRAME to large cytoplasmic foci. A similar effect was observed in shown). However, as shown in Fig. 1A, a strong increase in the leukaemic cell line U937 in response to LPS/IFNc treatment PRAME transcript levels was observed within 1 hour of combined (Fig. 2C). Quantitation of PRAME-containing foci in LPS/IFNc- treatment with LPS and IFNc. This increase was transient as treated and or control cells revealed a major change in the PRAME levels were lower at 4 hours post-treatment, and restored subcellular distribution of PRAME in response to LPS/IFNc to background levels within 24 hours, suggesting that turnover of treatment (Fig. 2E&F). PRAME mRNA may be relatively rapid. The induction of PRAME The polarised distribution of the PRAME-containing foci, by LPS/IFNc was inhibited by pre-treating cells with actinomycin suggested that these structures may represent the trans Golgi D for one hour prior to addition of LPS/IFNc (Fig. 1B), indicating network, and staining of HL60 cells with the 58K Golgi marker that the increase in PRAME levels is due to de novo transcription confirmed that these structures appear to be linked to the Golgi rather than altered stability of the transcripts. network and show considerable colocalisation with PRAME To examine whether LPS/IFNc results in increased translation (Fig. 2D). We noted that the nuclei of LPS/IFNc treated HL60 of PRAME transcripts, polysome gradients were prepared from and U937 cells appeared to undergo a morphological change extracts of HL60 cells treated or untreated with LPS and IFNc.As resulting in ‘kidney’ shaped nuclei being visible after 4 hours shown in Fig. 1C, within 4 hours post-treatment with LPS/IFNc, treatment (Fig. 2B&C), and that this phenotype was prevalent in PRAME transcripts were substantially enriched in polysome many of the treated cells, but less obvious in controls (Fig. 2E). fractions, as confirmed by densitometry (lower panels). In contrast, a control transcript (b-actin) showed little change. These results PRAME and the 58K Golgi marker accumulated at the apex of indicate that upregulation of PRAME gene expression by LPS/ the invaginated region (Fig. 2D, lower panels). Thus, we conclude IFNc in HL60 cells may be achieved not only through increased that in HL60 and U937 cells, cytoplasmic PRAME proteins are transcription, but also effects on translation of PRAME transcripts. targeted to the Golgi network following exposure to LPS/IFNc.
Recommended publications
  • The UBE2L3 Ubiquitin Conjugating Enzyme: Interplay with Inflammasome Signalling and Bacterial Ubiquitin Ligases
    The UBE2L3 ubiquitin conjugating enzyme: interplay with inflammasome signalling and bacterial ubiquitin ligases Matthew James George Eldridge 2018 Imperial College London Department of Medicine Submitted to Imperial College London for the degree of Doctor of Philosophy 1 Abstract Inflammasome-controlled immune responses such as IL-1β release and pyroptosis play key roles in antimicrobial immunity and are heavily implicated in multiple hereditary autoimmune diseases. Despite extensive knowledge of the mechanisms regulating inflammasome activation, many downstream responses remain poorly understood or uncharacterised. The cysteine protease caspase-1 is the executor of inflammasome responses, therefore identifying and characterising its substrates is vital for better understanding of inflammasome-mediated effector mechanisms. Using unbiased proteomics, the Shenoy grouped identified the ubiquitin conjugating enzyme UBE2L3 as a target of caspase-1. In this work, I have confirmed UBE2L3 as an indirect target of caspase-1 and characterised its role in inflammasomes-mediated immune responses. I show that UBE2L3 functions in the negative regulation of cellular pro-IL-1 via the ubiquitin- proteasome system. Following inflammatory stimuli, UBE2L3 assists in the ubiquitylation and degradation of newly produced pro-IL-1. However, in response to caspase-1 activation, UBE2L3 is itself targeted for degradation by the proteasome in a caspase-1-dependent manner, thereby liberating an additional pool of IL-1 which may be processed and released. UBE2L3 therefore acts a molecular rheostat, conferring caspase-1 an additional level of control over this potent cytokine, ensuring that it is efficiently secreted only in appropriate circumstances. These findings on UBE2L3 have implications for IL-1- driven pathology in hereditary fever syndromes, and autoinflammatory conditions associated with UBE2L3 polymorphisms.
    [Show full text]
  • The Yeast-Hyphal Transition of Candida Albicans
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 15 June 2021 doi:10.20944/preprints202106.0386.v1 Review From Jekyll to Hyde: The yeast-hyphal transition of Candida albicans Eve Wai Ling Chow 1, Li Mei Pang 2 and Yue Wang 1,3* 1 Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore 138673; [email protected] 2 National Dental Research Institute Singapore (NDRIS), National Dental Centre Singapore, 5 Second Hospi- tal Ave, Singapore 168938; [email protected] 3 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medi- cal Drive, Singapore 117597 * Correspondence: [email protected] Abstract: Candida albicans is a major fungal pathogen of humans, accounting for 15% of nosocomial infections with an estimated attributable mortality of 47%. C. albicans is usually a benign member of the human microbiome in healthy people. Under constant exposure to highly dynamic environmen- tal cues in diverse host niches, C. albicans has successfully evolved to adapt to both commensal and pathogenic lifestyles. The ability of C. albicans to undergo a reversible morphological transition from yeast to filamentous forms is a well-established virulent trait. Over the past few decades, a signifi- cant amount of research has been carried out to understand the underlying regulatory mechanisms, signaling pathways, and transcription factors that govern the C. albicans yeast-to-hyphal transition. This review will summarize our current understanding of well-elucidated signal transduction path- ways that activate C. albicans hyphal morphogenesis in response to various environmental cues and the cell cycle machinery involved in the subsequent regulation and maintenance of hyphal morpho- genesis.
    [Show full text]
  • Book of Abstracts
    13th Mee�ng of the 13. srečanje Slovenian Biochemical Society Slovenskega biokemijskega društva with Interna�onal Par�cipa�on z mednarodno udeležbo Book of Abstracts 24 ‐ 27 September 2019 Dobrna, Slovenia 13th Meeting of the Slovenian Biochemical Society with International Participation 13. srečanje Slovenskega biokemijskega društva z mednarodno udeležbo Book of Abstracts Knjiga povzetkov Dobrna, 24 ‐ 27 September 2019 i The 13th Meeting of the Slovenian Biochemical Society with International Participation is organised by the Slovenian Biochemical Society and the National Institute of Chemistry, Ljubljana, Slovenia. 13th Meeting of the Slovenian Biochemical Society with International Participation 13. srečanje Slovenskega biokemijskega društva z mednarodno udeležbo Editor: Matic Kisovec Technical Editors: Anja Golob‐Urbanc, Gašper Šolinc Published by: Slovenian Biochemical Society, Ljubljana Reviewed by: Matic Legiša, Anja Golob‐Urbanc, Gašper Šolinc Cover Design by: Matic Kisovec (graphics from vecteezy, freepik, smashicons) Organised by: National Institute of Chemistry, Ljubljana, Slovenia and the Slovenian Biochemical Society Printed by: Tiskarna knjigoveznica Radovljica d.o.o., Radovljica Circulation: 250 Complimentary publication CIP ‐ Kataložni zapis o publikaciji Narodna in univerzitetna knjižnica, Ljubljana 577.1(082) SLOVENIAN Biochemical Society. Meeting with International Participation (13 ; 2019 ; Dobrna) Book of abstracts = Knjiga povzetkov / 13th Meeting of the Slovenian Biochemical Society with International Participation
    [Show full text]
  • Identification of the Biosynthetic Gene Cluster of A-500359S In
    The Journal of Antibiotics (2009) 62, 325–332 & 2009 Japan Antibiotics Research Association All rights reserved 0021-8820/09 $32.00 www.nature.com/ja ORIGINAL ARTICLE Identification of the biosynthetic gene cluster of A-500359s in Streptomyces griseus SANK60196 Masanori Funabashi1, Koichi Nonaka1, Chieko Yada1, Masahiko Hosobuchi1, Nobuhisa Masuda2, Tomoyuki Shibata3 and Steven G Van Lanen4 A-500359s, produced by Streptomyces griseus SANK60196, are inhibitors of bacterial phospho-N-acetylmuramyl-pentapeptide translocase. They are composed of three distinct moieties: a 5¢-carbamoyl uridine, an unsaturated hexuronic acid and an aminocaprolactam. Two contiguous cosmids covering a 65-kb region of DNA and encoding 38 open reading frames (ORFs) putatively involved in the biosynthesis of A-500359s were identified. Reverse transcriptase PCR showed that most of the 38 ORFs are highly expressed during A-500359s production, but mutants that do not produce A-500359s did not express these same ORFs. Furthermore, orf21, encoding a putative aminoglycoside 3¢-phosphotransferase, was heterologously expressed in Escherichia coli and Streptomyces albus, yielding strains having selective resistance against A-500359B, suggesting that ORF21 phosphorylates the unsaturated hexuronic acid as a mechanism of self-resistance to A-500359s. In total, the data suggest that the cloned region is involved in the resistance, regulation and biosynthesis of A-500359s. The Journal of Antibiotics (2009) 62, 325–332; doi:10.1038/ja.2009.38; published online 29 May 2009 Keywords:
    [Show full text]
  • Phosphorylation and Mechanistic Regulation of a Novel Ikk
    PHOSPHORYLATION AND MECHANISTIC REGULATION OF A NOVEL IKK SUBSTRATE, ITCH By JESSICA MARIE PEREZ Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Dissertation Advisor: Dr. Derek W. Abbott Department of Pathology CASE WESTERN RESERVE UNIVERSITY January 2018 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Jessica Marie Perez candidate for the Doctor of Philosophy degree*. (signed) Dr. George Dubyak (chair of the committee) Dr. Pamela Wearsch Dr. Theresa Pizarro Dr. Clive Hamlin Dr. Brian Cobb Dr. Derek Abbott (date) October 2, 2017 *We also certify that written approval has been obtained for any proprietary material contained therein. Table of Contents List of Tables ........................................................................................................ v List of Figures ..................................................................................................... vi Acknowledgements .......................................................................................... viii List of Abbreviations .......................................................................................... ix Abstract ............................................................................................................... xi Chapter 1: Introduction ....................................................................................... 1 1.1 Introduction .........................................................................................
    [Show full text]
  • Download the 2015 Abstract Booklet
    WELCOME Dear CRINA Research Day Attendee, Thank you for joining us at the second annual CRINA Research Day. Last year at our inaugural event we welcomed over 300 attendees and featured more than 150 posters from many departments and faculties across campus. We are happy to announce that many of those attendees signed up to be members of CRINA, forming the core of our cancer research community. One year later, we continue to build our cancer research community by hosting a cancer-themed Research Day yet again. This year, we have given trainees an opportunity to both organize the program and present their work orally to our cancer research community at the University of Alberta. Further, we are emphasizing multidisciplinary collaborations that are so important for studying the complexities of cancer, by featuring team oral presentations. We hope that you continue to explore what the University of Alberta has to offer in the cancer research sphere and grow your network of collaborators through future CRINA Research Days. CRINA as an institute has a well-established reporting structure with operations committees and advisory boards. At our core, we continue to strengthen connections within our cancer research community by hosting events throughout the year such as seminars and symposia. Our leadership team is working on defining U of A cancer research strengths in terms of both, research brilliance and available equipment, with plans to build on this excellence to accelerate discovery and innovation. CRINA also represents the interests of its members as a unified voice on the provincial stage, working with AHS, AIHS and ACF.
    [Show full text]
  • Structural and Functional Studies of Pseudomurein Peptide Ligases In
    Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. ii Structural and functional studies of pseudomurein peptide ligases in methanogenic archaea A dissertation presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Biochemistry Massey University, Manawatu, New Zealand. Bishwa Prakash Subedi 2018 Abstract Prokaryotes are classified as Archaea and Bacteria in the tree of life and have several distinguishing characteristics, among which the cell wall is one of the most essential and early evolving. Cell walls serve a number of essential functions including protection against osmotic stress, maintenance of cell shape, reduction of lateral gene transfer, and protection from viruses. The cell walls in Bacteria are predominantly comprised of peptidoglycan (murein) whereas Archaea contain a wide range of cell wall types, none of them being murein. However, methanogens of the order Methanobacteriales and Methanopyrales contain pseudomurein that shares an overall architectural structure similar to that of murein with a glycan backbone that is cross-linked by a peptide. Understanding the enzymatic steps for pseudomurein pentapeptide biosynthesis and structural information of these enzymes, could be key to resolving the evolutionary history of cell wall synthesis and was the focus of this project. Analysis of the sequences and gene clusters of the murein peptide ligase genes suggested that analogous putative pseudomurein peptide ligases exist in methanogens. Moreover, the structures of two pseudomurein peptide ligases, pMurE and pMurC, the first of any archaeal peptide ligase, have been determined and their structural homology with bacterial murein ligase MurE and MurC, respectively, was analysed.
    [Show full text]
  • Download Product Insert (PDF)
    PRODUCT INFORMATION D-Glutamic Acid Item No. 31503 CAS Registry No.: 6893-26-1 Synonyms: Glutamic Acid, NSC 77686 O O MF: C5H9NO4 FW: 147.1 HO OH ≥95% Purity: NH Supplied as: A crystalline solid 2 Storage: -20°C Stability: ≥2 years Information represents the product specifications. Batch specific analytical results are provided on each certificate of analysis. Laboratory Procedures D-Glutamic acid is supplied as a crystalline solid. Aqueous solutions of D-glutamic acid can be prepared by directly dissolving the crystalline solid in aqueous buffers. The solubility of D-glutamic acid in PBS, pH 7.2, is approximately 1 mg/ml. We do not recommend storing the aqueous solution for more than one day. Description D-glutamic acid is an amino acid and a component of bacterial peptidoglycan.1 It is linked to UDP-N- acetylmuramoyl-L-alanine (UDP-MurNAc-L-Ala) by the muramyl ligase MurD to form UDP-MurNAc-L-Ala- D-glutamic acid, a building block in the biosynthesis of bacterial peptidoglycan. D-glutamic acid is also a component of poly-γ-glutamic acid, a polymer produced by Bacillus.2 References 1. Kouidmi, I., Levesque, R.C., and Paradis-Bleau, C. The biology of Mur ligases as an antibacterial target. Mol. Microbiol. 94(2), 242-253 (2014). 2. Ogasawara, Y., Shigematsu, M., Sato, S., et al. Involvement of peptide epimerization in poly-γ-glutamic acid biosynthesis. Org. Lett. 21(11), 3972-3975 (2019). WARNING CAYMAN CHEMICAL THIS PRODUCT IS FOR RESEARCH ONLY - NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE. 1180 EAST ELLSWORTH RD SAFETY DATA ANN ARBOR, MI 48108 · USA This material should be considered hazardous until further information becomes available.
    [Show full text]
  • Octot of $!)Ilos(Opl)P
    Tilfe^^iJ BIOCHEMICAL STUDIES ON ANTIBIOTIC RESISTANCE AMONG STAPHYLOCOCCI FROM EYES AND OTHER CLINICAL SOURCES IN HEALTH AND DISEASE ABSTRACT THESIS SUBMITTED FOR THE AWARD OF THE DEGREE OF ©octot of $!)ilos(opl)p Piocfjemisitrp BY JAVID AHMAD DAR DEPARTMENT OF BIOCHEMISTRY & MICROBIOLOGY SECTION, INSTITUTE OF OPHTHALMOLOGY JAWAHARLAL NEHRU MEDICAL COLLEGE FACULTY OF MEDICINE ALIGARH MUSLIM UNIVERSITY ALIGARH-202002 (INDIA) 2003 •XBESlS Oor.-.V^'*^ Vsd •'« '4 .'-LGrcOd THESIS Biochemical Studies on Antibiotic Resistance among Staphylococci from Eyes and other Clinical Sources in Health and Disease Abstract The emergence of multidrug-resistant bacteria is a phenomenon of concem to the clinician and the pharmaceutical industry, as it is the major cause of failure in the treatment of infectious diseases. Staphylococci have a record of developing resistance quickly and successfully to antibiotics. This defensive response is a consequence of the acquisition and transfer of antibiotic resistance plasmids and the possession of intrinsic resistance mechanisms. The acquired defense systems by staphylococci may have originated from antibiotic-producing organisms, where they may have been developed and then passed on to other genera. There are reports of emergence and high occurrence of staphylococcus strains resistant to methicillin, especially MRSA, from various parts of the World. These organisms are mostly resistant to multiple antibiotics; therefore the treatment of infections due to these organisms and their eradication is very difficult. The present study was undertaken with the aim of determining epidemiology of clinical and carrier staphylococci and biochemical studies of their acquisition and dissemination of resistance. The prevalence of methicillin-resistant Staphylococci was determined in 750 subjects infected/colonized with staphylococci providing 850 isolates.
    [Show full text]
  • Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?
    Hindawi Publishing Corporation Mediators of Inflammation Volume 2016, Article ID 3481371, 13 pages http://dx.doi.org/10.1155/2016/3481371 Review Article Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance? Gloria Lopez-Castejon1 and Mariola J. Edelmann2 1 Manchester Collaborative Centre for Inflammation Research, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK 2Department of Microbiology and Cell Science, College of Agricultural and Life Sciences, University of Florida, 1355 Museum Drive, Gainesville, FL 32611-0700, USA Correspondence should be addressed to Gloria Lopez-Castejon; [email protected] Received 24 March 2016; Revised 1 June 2016; Accepted 4 July 2016 Academic Editor: Luca Cantarini Copyright © 2016 G. Lopez-Castejon and M. J. Edelmann. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Inflammation is a protective response of the organism to tissue injury or infection. It occurs when the immune system recognizes Pathogen-Associated Molecular Patterns (PAMPs) or Damage-Associated Molecular Pattern (DAMPs) through the activation of Pattern Recognition Receptors. This initiates a variety of signalling events that conclude in the upregulation of proinflammatory molecules, which initiate an appropriate immune response. This response is tightly regulated since any aberrant activation of immune responses would have severe pathological consequences such as sepsis or chronic inflammatory and autoimmune diseases. Accumulative evidence shows that the ubiquitin system, and in particular ubiquitin-specific isopeptidases also known as deubiquitinases (DUBs), plays crucial roles in the control of these immune pathways. In this review we will give an up-to-date overviewontheroleofDUBsintheNF-B pathway and inflammasome activation, two intrinsically related events triggered by activation of the membrane TLRs as well as the cytosolic NOD and NLR receptors.
    [Show full text]
  • Negative Regulation of the Innate Immune Response Through Proteasomal Degradation and Deubiquitination
    viruses Review Negative Regulation of the Innate Immune Response through Proteasomal Degradation and Deubiquitination Valentina Budroni and Gijs A. Versteeg * Max Perutz Labs, Department of Microbiology, Immunobiology, and Genetics, University of Vienna, Vienna Biocenter (VBC), 1030 Vienna, Austria; [email protected] * Correspondence: [email protected] Abstract: The rapid and dynamic activation of the innate immune system is achieved through complex signaling networks regulated by post-translational modifications modulating the subcellular localization, activity, and abundance of signaling molecules. Many constitutively expressed signaling molecules are present in the cell in inactive forms, and become functionally activated once they are modified with ubiquitin, and, in turn, inactivated by removal of the same post-translational mark. Moreover, upon infection resolution a rapid remodeling of the proteome needs to occur, ensuring the removal of induced response proteins to prevent hyperactivation. This review discusses the current knowledge on the negative regulation of innate immune signaling pathways by deubiquitinating enzymes, and through degradative ubiquitination. It focusses on spatiotemporal regulation of deubiquitinase and E3 ligase activities, mechanisms for re-establishing proteostasis, and degradation through immune-specific feedback mechanisms vs. general protein quality control pathways. Keywords: ubiquitin; deubiquitinase; E3 ligase; innate immune system; proteasome; cytokine Citation: Budroni, V.;
    [Show full text]
  • Mycobacterium Tuberculosis Induced Transcription in Macrophages: the Role of TPL2/ERK Signalling in the Negative Regulation of T
    Mycobacterium tuberculosis induced transcription in macrophages: the role of TPL2/ERK signalling in the negative regulation of type I interferon production and implications for control of tuberculosis John Benson Ewbank August 2012 Division of Immunoregulation MRC National Institute for Medical Research The Ridgeway, Mill Hill London NW7 1AA Submitted to University College London for the Degree of Doctor of Philosophy I, John Benson Ewbank, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis Abstract Abstract Mycobacterium tuberculosis is an important global cause of mortality and morbidity. The major host cell of Mycobacterium tuberculosis is the macrophage, and Mycobacterium tuberculosis is able to subvert the macrophage response in order to survive and replicate. The majority of infected individuals mount an immune response capable of controlling Mycobacterium tuberculosis infection. This requires the cytokines IL-12, TNFα, IL-1 and IFNγ, which promote eradication or control of infection. However, other immune factors, including IL-10 and type I IFN, can inhibit this protective response. In this study we have used microarray analysis to study the temporal response of macrophages to Mycobacterium tuberculosis infection, in an unbiased fashion. In response to Mycobacterium tuberculosis infection, macrophages produced cytokines and chemokines, upregulated genes involved with major histocompatability class I antigen presentation, activated both pro- and anti-apoptotic genes and downregulated many genes involved in cell-division and metabolism. We also observed the early induction of genes regulated by the extracellular-regulated kinase (ERK) MAP kinase pathway, and the upregulation of genes known to be induced by type I IFN, leading us to further investigate the role of these pathways in the macrophage response to Mycobacterium tuberculosis.
    [Show full text]